This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is Superior Group (SGC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Superior Group (SGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SGCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Affirm Holdings (AFRM) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Affirm Holdings (AFRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AFRMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AZNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Carnival (CCL): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Carnival (CCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Comfort Systems (FIX) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Comfort Systems (FIX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
FIXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Bitfarms (BITF): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Bitfarms (BITF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BITFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Diversified Energy Company PLC (DEC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Diversified Energy Company PLC (DEC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DECPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Progressive (PGR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Progressive (PGR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PGRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VKTXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in MakeMyTrip (MMYT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in MakeMyTrip (MMYT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MMYTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
AppFolio (APPF) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AppFolio (APPF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
APPFNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Trip.com (TCOM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Trip.com (TCOM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TCOMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in ACM Research (ACMR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ACM Research (ACMR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ACMRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in MINISO Group Holding Limited (MNSO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), MINISO Group Holding Limited (MNSO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MNSOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think CrowdStrike (CRWD) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CrowdStrike (CRWD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRWDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Itron (ITRI): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Itron (ITRI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ITRIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Dorian LPG (LPG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Dorian LPG (LPG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LPGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Humacyte, Inc. (HUMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HUMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
JD.com (JD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JD.com (JD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in GE Vernova (GEV) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), GE Vernova (GEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
GEVPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Wix.com (WIX): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Wix.com (WIX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
WIXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in APTIV HLDS LTD (APTV) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for APTIV HLDS LTD (APTV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
APTVPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See CRH (CRH) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CRH (CRH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CRHPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Grab (GRAB): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Grab (GRAB) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
GRABNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Sony (SONY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Sony (SONY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SONYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth